Children's brain development is linked to the trajectory of epigenetic-based inflammatory scores
Author Block: J. Chuah, A. M. A. Manahan, S. Y. Chan, H. Pei, M. Fortier, M. Meaney, A. P. Tan; Singapore/SG
Purpose: Dysregulation of immune activation has been consistently shown in patients with mental health disorders. In this study, we mapped the trajectories of DNA-methylation based inflammation scores and examined how these trajectories relate to exposure to maternal depression, subsequent cognitive outcomes, and brain development at multiple levels.
Methods or Background: Inflammation scores were calculated for 293 children from DNA methylation data based on epigenome-wide association studies of serum C-reactive proteins at ages 9 and 48 months. We stratify these children into quartiles based on their inflammation scores at baseline and map the trajectories of inflammation scores for each quartile. Next, we examined if children with different inflammation score trajectories have different exposure to maternal depression, executive function performance, and brain changes evaluated using multimodal MRI at ages 4.5, 6.0, and 7.0 years.
Results or Findings: We observed a decreasing trend of our DNA-methylation based inflammation scores, primarily driven by children with higher levels of inflammation scores at baseline. Children with lower levels of inflammation scores at 9M and a slower decrease in inflammation scores between 9M and 48M were exposed to higher levels of maternal depressive symptoms and showed poorer executive function performance at ages 4.5 and 7. Children with different inflammation score trajectories exhibit significantly different brain structure and function, involving predominantly brain regions involved in executive function performance, emotion, and reward processing.
Conclusion: Children with lower baseline inflammation scores and slower rate of decrease across childhood are exposed to higher levels of maternal depression, possibly related to a blunted immune response from chronic stress exposure. This has a significant downstream impact on cognitive and brain development at multiple levels.
Limitations: Evaluation of executive function performance with questionnaires
Funding for this study: This research was supported by grants NMRC/TCR/004-NUS/2008 and NMRC/TCR/012-NUHS/2014 from the Singapore National Research Foundation (NRF) under the Translational and Clinical Research Flagship and grant OFLCG/MOH-000504 from the Open Fund Large Collaborative Grant Programmes and administered by the Singapore Ministry of Health’s National Medical Research Council (NMRC), Singapore. In RIE2025, GUSTO is supported by funding from the NRF’s Human Health and Potential (HHP) Domain, under the Human Potential Programme. Additional funding was provided by the Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A*STAR), Singapore. MJM is supported by funding from the Hope for Depression Research Foundation, USA, the Toxic Stress Network of the JPB Foundation, USA, the Jacobs Foundation, Switzerland, and the NRF and A*STAR’s Human Potential Programme (H22P0M0001), Singapore. SYC is supported by funding from the NMRC Open Fund – Young Individual Research Grant (MOH-001149-00). EHT is supported by the NMRC Clinician-Scientist Award (CSA) (MOH-001415). APT is supported by funding from the NMRC Transition Award (MOH-001273-00) and A*STAR (Brain-Body Initiative, iGrants call ID #21718).
Has your study been approved by an ethics committee? Yes
Ethics committee - additional information: The study was approved by the National Healthcare Group Domain Specific Review Board (D/2009/021 and B/2014/00411) and the SingHealth Centralized Institutional Review Board (D/2018/2767 and A/2019/2406). All investigations were conducted according to the principles expressed in the Declaration of Helsinki. Written consent was obtained from all guardians on behalf of the enrolled children.